URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michelle Janelsins

Concepts (112)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Breast Neoplasms
6
2010
673
1.420
Why?
Antineoplastic Agents
5
2009
619
1.280
Why?
Cognition Disorders
2
2011
286
1.200
Why?
Neoplasms
7
2009
739
1.160
Why?
Tai Ji
3
2010
22
0.980
Why?
Survivors
5
2009
118
0.840
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2011
429
0.730
Why?
Dentate Gyrus
1
2010
26
0.720
Why?
Insulin-Like Growth Factor I
1
2010
104
0.670
Why?
Blood-Brain Barrier
1
2010
108
0.670
Why?
Gene Expression Regulation, Neoplastic
1
2011
256
0.650
Why?
Alzheimer Disease
2
2008
294
0.620
Why?
Insulin
1
2011
668
0.600
Why?
Cytokines
1
2011
565
0.580
Why?
Inflammation
1
2008
534
0.470
Why?
Neurons
2
2008
1083
0.470
Why?
Tumor Necrosis Factor-alpha
1
2008
659
0.460
Why?
Exercise
2
2009
182
0.320
Why?
Quality of Life
3
2009
502
0.310
Why?
Humans
16
2008
36274
0.280
Why?
Female
11
2009
19838
0.260
Why?
Aged
7
2009
7269
0.260
Why?
Middle Aged
8
2009
9837
0.250
Why?
Geriatric Assessment
2
2011
158
0.220
Why?
Boronic Acids
1
2012
29
0.200
Why?
Pyrazines
1
2012
33
0.200
Why?
Antibodies, Monoclonal, Humanized
1
2012
87
0.200
Why?
Multiple Myeloma
1
2012
76
0.200
Why?
Double-Blind Method
2
2010
992
0.190
Why?
Adult
5
2010
11351
0.190
Why?
Antineoplastic Agents, Hormonal
1
2011
46
0.190
Why?
National Institutes of Health (U.S.)
1
2011
63
0.190
Why?
Brain
2
2008
1214
0.190
Why?
Benzhydryl Compounds
1
2010
13
0.180
Why?
Interleukin-8
1
2011
111
0.180
Why?
Resistance Training
1
2010
7
0.180
Why?
Bone Density Conservation Agents
1
2011
51
0.180
Why?
tau Proteins
2
2008
97
0.180
Why?
Bromodeoxyuridine
1
2010
66
0.180
Why?
Neurogenesis
1
2010
29
0.180
Why?
Vitamin D
1
2011
71
0.180
Why?
Chemokine CCL2
1
2011
127
0.180
Why?
Radiation Injuries
1
2011
131
0.180
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Fluorouracil
1
2010
78
0.180
Why?
Paclitaxel
1
2010
58
0.170
Why?
Doxorubicin
1
2010
107
0.170
Why?
Cyclophosphamide
1
2010
174
0.170
Why?
Weight Loss
1
2010
74
0.170
Why?
Aged, 80 and over
3
2010
2529
0.170
Why?
Medicare
1
2011
129
0.170
Why?
Pilot Projects
1
2011
442
0.170
Why?
Tumor Markers, Biological
1
2011
229
0.170
Why?
Mice
3
2008
6111
0.170
Why?
Plaque, Amyloid
1
2009
3
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.170
Why?
Tauopathies
1
2009
5
0.170
Why?
Mice, Transgenic
2
2008
749
0.160
Why?
Biomedical Research
1
2011
139
0.160
Why?
Fatigue
1
2010
124
0.160
Why?
Transgenes
1
2008
72
0.160
Why?
Analysis of Variance
1
2011
736
0.160
Why?
Interleukin-6
1
2011
339
0.160
Why?
Dependovirus
1
2008
65
0.160
Why?
Amyloid beta-Peptides
1
2008
57
0.150
Why?
Myelin Sheath
1
2009
80
0.150
Why?
Microglia
1
2008
76
0.150
Why?
Brain Neoplasms
1
2011
281
0.150
Why?
Mice, Inbred C57BL
2
2009
1675
0.150
Why?
Smoking
1
2011
399
0.150
Why?
Bone and Bones
1
2010
355
0.140
Why?
Genetic Vectors
1
2008
339
0.140
Why?
Macrophages
1
2008
346
0.140
Why?
Cell Proliferation
1
2010
515
0.140
Why?
Male
7
2009
19675
0.130
Why?
Prostatic Neoplasms
1
2011
555
0.130
Why?
Aging
1
2011
707
0.120
Why?
Risk Factors
1
2011
2345
0.120
Why?
Animals
3
2008
16093
0.120
Why?
Time Factors
1
2011
3182
0.110
Why?
Age Factors
3
2009
1128
0.100
Why?
Osteoporosis
2
2010
85
0.090
Why?
Prevalence
2
2009
562
0.080
Why?
United States
2
2011
2688
0.050
Why?
Nutrition Disorders
1
2011
15
0.050
Why?
Organizational Innovation
1
2011
28
0.050
Why?
Hearing Disorders
1
2011
25
0.050
Why?
Urinary Incontinence
1
2011
46
0.050
Why?
Vitamin D Deficiency
1
2011
36
0.050
Why?
Accidental Falls
1
2011
50
0.050
Why?
Syndrome
1
2011
208
0.050
Why?
Memory Disorders
1
2011
48
0.050
Why?
Vision Disorders
1
2011
73
0.040
Why?
Neoplasm Staging
1
2011
338
0.040
Why?
Bone Density
1
2011
111
0.040
Why?
Collagen Type I
1
2010
49
0.040
Why?
Placebos
1
2010
178
0.040
Why?
Feasibility Studies
1
2010
202
0.040
Why?
Comorbidity
1
2011
380
0.040
Why?
Health Status
1
2011
283
0.040
Why?
Survival Rate
1
2011
618
0.040
Why?
Nerve Fibers, Myelinated
1
2009
38
0.040
Why?
Continental Population Groups
1
2009
121
0.040
Why?
Logistic Models
1
2011
611
0.040
Why?
Prognosis
1
2011
1083
0.040
Why?
Peptides
1
2010
285
0.040
Why?
Bone Resorption
1
2010
241
0.040
Why?
Sex Factors
1
2009
597
0.040
Why?
Biological Markers
1
2010
560
0.040
Why?
Depression
1
2011
432
0.030
Why?
Retrospective Studies
1
2011
2267
0.030
Why?
Adolescent
1
2010
4766
0.020
Why?

Visualizations


Janelsins's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department